Beta cell mass and function are decreased to varying degrees in diabetes. Islet cell replacement or regenerative therapy may offer great therapeutic promise to people with diabetes. In addition to primary pancreatic β cells, recent studies on regeneration of functional insulin producing cells (IPCs) revealed that several alternative cell sources, including embryonic stem cells, induced pluripotent stem cells and adult stem cells, can generate IPCs by differentiation, reprogramming, and trans-differentiation. In this review, we discuss stem cells as a potential alternative cell source for the treatment of diabetes.
Research status and prospect of stem cells in the treatment of diabetes mellitus
Xiaofang Liu,Yunfang Wang,Yali Li,X. Pei
Published 2013 in Science China Life Sciences
ABSTRACT
PUBLICATION RECORD
- Publication year
2013
- Venue
Science China Life Sciences
- Publication date
2013-04-07
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-50 of 50 references · Page 1 of 1
CITED BY
Showing 1-29 of 29 citing papers · Page 1 of 1